2023: Postdoctoral Research Position in Structural Immunology/Vaccinology
The Mousa Laboratory at the University of Georgia (UGA) Center for Vaccines and Immunology (CVI) in Athens, GA is seeking TWO creative and enthusiastic postdoctoral fellows to drive forward research projects focused on monoclonal antibody therapies and epitope-focused vaccine design. These are multidisciplinary projects with enormous training opportunity in human immunology, virology, bacteriology, animal models of infection, and structural biology, including X-ray crystallography and cryo- electron microscopy. The Mousa Laboratory studies monoclonal antibodies as therapeutics and to inform vaccine design.
2023: Tenure-Track Investigator, Vaccine Research Center
The Vaccine Research Center (VRC), part of the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH), has an open Tenure-Track Investigator recruitment opportunity. The position announcement and application details are on the NIAID Careers website.
The VRC is seeking highly creative scientists as Tenure-Track Investigators (equivalent to an assistant or associate professor-level academic faculty) to advance visionary and field-leading basic, translational, and applied research to develop safe and effective novel vaccines and therapeutics against infectious diseases. Expertise in immunology, virology, structural biology, bioengineering, and closely related fields is desired.
The VRC seeks to discover and develop novel vaccines and biologics to address the challenges of an ever-evolving landscape of emerging and re-emerging infectious diseases. The center meets these challenges with a diverse, multidisciplinary, and integrated team of specialists who work collaboratively to drive research programs at the forefront of scientific discovery. As extremely productive members of the NIAID/NIH Intramural Research Program, VRC scientists, researchers, and clinicians contribute high-impact research that advances fundamental knowledge of microbiology and immunology, the evaluation of novel vaccine platforms, and the rapid translation of discoveries into new vaccines and biologic products for clinical studies. Research at the VRC also encompasses product development, manufacturing, and licensure through strategic partnerships established with external collaborators. The VRC’s extensive research portfolio includes HIV, coronaviruses, influenza, malaria, tuberculosis, flaviviruses, filoviruses, alphaviruses, paramyxoviruses, and other biothreats and emerging pathogens.
Applications will be reviewed starting April 15, 2023 and will be accepted until the positions are filled.
Inquiries may also be directed to Ms. Sarah Austin.